University of Patras
Μελέτη του παράγοντα αδειοδότησης της αντιγραφής Cdt1 καθώς και της υπεροικογένειας της Geminin στην πρόκληση γονιδιωματικής αστάθειας και στον καθορισμό της κυτταρικής μοίρας
Abstract
dc:descriptionGenome stability is mainly preserved through normal progression of the cell cycle and regulation of DNA replication in time and space. From late mitosis and during G1, pre- replicative complexes are formed in chromatin, establishing the origins of replication, which will fire in the subsequent S phase. Pre-replicative complexes are formed through recruitment of MCM2-7 through corporation of ORC1-6, CDT1 and CDC6. Deregulated expression of CDT1 and CDC6 induces re-replication, replication stress and DNA damage. Gene amplification is a type of genomic instability, which leads to oncogene activation and acquired drug resistance. Here, we studied whether re-replication is a potent inducer of gene copy number increase. CDT1 and CDC6 overexpression promoted DHFR gene duplication and induced resistance to methotrexate. ATM/ATR checkpoint activation was required for re-replication induced gene amplification. Multiple repair pathways were activated upon re-replication induction. RAD52 dependent repair participated in resolution of re-replication intermediates to generate DHFR duplications, a process inhibited by 53BP1. Cells lacking RAD52 and overexpressing CDT1 and CDC6 showed exacerbated DNA damage, abnormal chromosome segregation and cell death. Overall, re-replication is a novel mechanism of gene copy number gain formation. Overexpression of CDT1 or Geminin depletion promotes origin re- licensing and re-firing, formation of double strand breaks and apoptosis. Here, we examined the anti-cancer potential of small chemical compounds targeting CDT1/Geminin protein-protein interaction. The small chemical compounds tested here showed efficient inhibition/disruption of CDT1-Geminin protein complex in cancer cells. Chemical compound #1 induced double strand breaks, inhibition of DNA synthesis and S/G2 cell cycle arrest, in a dose dependent manner, phenocopying CDT1 overexpression or Geminin depletion. Moreover, chemical compound #1 promoted cancer cell death without affecting normal cell proliferation. CDT1 and Geminin abnormal expression has been reported to participate in cancer development and progression either as oncogenes or as proliferation markers. In order to delineate Cdt1 and Geminin role in cancer we performed chemical induced carcinogenesis in the murine colon. Mice overexpressing Cdt1 and/or lacking Geminin developed a higher number of tumors with bigger size compared to control mice. Tumors overexpressing CDT1 and/or lacking Geminin harbored increased DNA damage and showed aggressive characteristics. Increased origin licensing was observed in tumors and intestinal crypts of mice overexpressing CDT1 and lacking Geminin. Therefore, deregulation of Cdt1 and Geminin expression may enhance colorectal carcinogenesis though aberrant origin licensing in vivo. Overall, we identified that DNA re- replication promotes gene copy number gains, a process which evokes proliferative advantage to cells. Moreover, we studied the specificity of small chemical compounds targeting CDT1/Geminin protein-protein interaction, their mechanism of action as well as their anticancer potential. In the last part of the thesis, we showed that Cdt1 overexpression and/or Geminin depletion participates in colorectal cancer progression through deregulation of the origin licensing program.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Petropoulos, Michail
- Πετρόπουλος, Μιχαήλ
Subjects
dc:subject × 13Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48693